DiagXtra® Non-Invasive Prenatal Testing (GPD)Back

One step ahead in monitoring health status of fetus, more comprehensive preparation for a healthy baby

 

Benefits of DiagXtra®Non-Invasive Prenatal Testing (NIPT):

Most chromosomal diseases develop when eggs are fertilized. They are random events that could happen to any pregnancy from completely healthy parents. In addition, according to statistics, parents who give birth later in life tend to have a higher chance of carrying babies affected by chromosomal abnormalities.

 

This test can be done at as early as the 10th week of pregnancy. It can accurately determine the risk of fetus experiencing disorders related to chromosomal abnormalities, which can further result in the baby's premature death, intellectual problems, hypoplasia or mental retardation. Based on test results, doctors can offer professional advice on follow-up and parents can take well-informed actions one step ahead.

 

DiagXtra® is the first step in safeguarding the health of your baby

Testing Items Include :

3 Items         4 Items
Trisomies ︱ Sex Chromosome Aneuploidies
Trisomies

  • T13 Patau Syndrome
  • T18 Edwards Syndrome
  • T21 Down Syndrome

Sex Chromosome Aneuploidies

  • XYY Jacob's Syndrome
  • XXX Triple-X Syndrome
  • XXY Klinefelter Syndrome
  • X0 Turner Syndrome/Monosomy

It can also show the Gender of the fetus and is applicable to Twin Pregnancies.

 

Safe Sampling & Eliminates the Risk of Miscarriage

DiagXtra®Non-Invasive Prenatal Testing can be performed before the child is born. Because the chromosomal DNA in the fetal cells can be released into the maternal blood circulation, only 18ml of maternal blood is required for testing, without the need of amniocentesis or collection of villi (fetal fluid or villi) to avoid the risk of miscarriage.

 

Comparison of Prenatal Testing

 

Suitable For

  • All pregnant women (Especially for pregnant women 35 years of age or older or those who are not suitable to undergo invasive prenatal examination)
  • Pregnant women with a history of inertial miscarriage
  • IVF pregnancy
  • Pregnant women with a high risk of aneuploidy indicated by fetal ultrasound
  • Pregnant women at risk of placenta previa and miscarriage or HBV infection
  • Women with twin pregnancy
  • Parents wishing to understand the health status of the baby

 

Test Features

SIMPLE : Only 18 ml of maternal blood is required to complete the test
QUALITY : The FIRST private medical laboratory in Hong Kong
ACCURATE : Up to 99.9% accuracy

SAFE & RELIABLE : Eliminate the risk of invasive diagnosis

 

 
 
 
Feature image-01

One step ahead in monitoring health status of fetus, more comprehensive preparation for a healthy baby

 

Benefits of DiagXtra®Non-Invasive Prenatal Testing (NIPT):

Most chromosomal diseases develop when eggs are fertilized. They are random events that could happen to any pregnancy from completely healthy parents. In addition, according to statistics, parents who give birth later in life tend to have a higher chance of carrying babies affected by chromosomal abnormalities.

 

This test can be done at as early as the 10th week of pregnancy. It can accurately determine the risk of fetus experiencing disorders related to chromosomal abnormalities, which can further result in the baby's premature death, intellectual problems, hypoplasia or mental retardation. Based on test results, doctors can offer professional advice on follow-up and parents can take well-informed actions one step ahead.

 

DiagXtra® is the first step in safeguarding the health of your baby

Testing Items Include :

3 Items         4 Items
Trisomies ︱ Sex Chromosome Aneuploidies
Trisomies

  • T13 Patau Syndrome
  • T18 Edwards Syndrome
  • T21 Down Syndrome

Sex Chromosome Aneuploidies

  • XYY Jacob's Syndrome
  • XXX Triple-X Syndrome
  • XXY Klinefelter Syndrome
  • X0 Turner Syndrome/Monosomy

It can also show the Gender of the fetus and is applicable to Twin Pregnancies.

 

Safe Sampling & Eliminates the Risk of Miscarriage

DiagXtra®Non-Invasive Prenatal Testing can be performed before the child is born. Because the chromosomal DNA in the fetal cells can be released into the maternal blood circulation, only 18ml of maternal blood is required for testing, without the need of amniocentesis or collection of villi (fetal fluid or villi) to avoid the risk of miscarriage.

 

Comparison of Prenatal Testing

 

Suitable For

  • All pregnant women (Especially for pregnant women 35 years of age or older or those who are not suitable to undergo invasive prenatal examination)
  • Pregnant women with a history of inertial miscarriage
  • IVF pregnancy
  • Pregnant women with a high risk of aneuploidy indicated by fetal ultrasound
  • Pregnant women at risk of placenta previa and miscarriage or HBV infection
  • Women with twin pregnancy
  • Parents wishing to understand the health status of the baby

 

Test Features

SIMPLE : Only 18 ml of maternal blood is required to complete the test
QUALITY : The FIRST private medical laboratory in Hong Kong
ACCURATE : Up to 99.9% accuracy

SAFE & RELIABLE : Eliminate the risk of invasive diagnosis

 



DiagXtra® Non-Invasive Prenatal Testing (GPD) Service Procedure

The principle of DiagXtra® Non-Invasive Prenatal Testing (GPD)

Fetal cell-free DNA is released regularly into maternal blood circulation. 

With only the maternal blood sample, we can detect the cell-free DNA of the fetus.

Return To Top

Service Procedure

PART 1 : Contact clinic or make the appointment though Diagcor customer service hotline +852 51805747

PART 2 : Draw sample from the clinic

PART 3 : Receive Report

PART 4 : Once the report is ready, the clinic will inform you to collect your report. If you need report counselling service, please contact the clinic.

Return To Top
Enquiry Now